Viewing StudyNCT06101329



Ignite Creation Date: 2024-05-06 @ 7:42 PM
Last Modification Date: 2024-10-26 @ 3:12 PM
Study NCT ID: NCT06101329
Status: RECRUITING
Last Update Posted: 2024-06-12
First Post: 2023-10-20

Brief Title: Study of Lenacapavir and EmtricitabineTenofovir Disoproxil Fumarate FTDF in Prevention of HIV in Cisgender Women in the United States HPTN 102
Sponsor: Gilead Sciences
Organization: Gilead Sciences

Organization Data

Organization: Gilead Sciences
Class: INDUSTRY
Study ID: GS-US-528-6020
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Gilead Sciences
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
HIV Prevention Trials Network NETWORK